Use of interval-specific likelihood ratios improves clinical interpretation of serum FLC results for the diagnosis of malignant plasma cell disorders

Clinica Chimica Acta

Volumn 410, Issue 1-2, 2009, Pages 54-58

  Vermeersch, Pieter ^a   Vercammen, Martine ^b   Holvoet, Annelies ^a   Broeck, Isabelle Vande ^b   Delforge, Michel ^a   Bossuyt, Xavier ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

B cells; Diagnosis; Hematological malignancies; Immunoglobulin light chain; Immunohematology; Multiple myeloma; Plasma cells

Indexed keywords

IMMUNOGLOBULIN LIGHT CHAIN;

AMYLOIDOSIS; ARTICLE; CONTROLLED STUDY; HEMATOLOGIC DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALIGNANT PLASMA CELL DISORDER; MONOCLONAL IMMUNOGLOBULINEMIA; MULTIPLE MYELOMA; PLASMACYTOMA; PRIORITY JOURNAL; PROBABILITY; SEROLOGY;

AMYLOIDOSIS; CASE-CONTROL STUDIES; HUMANS; IMMUNOGLOBULIN KAPPA-CHAINS; IMMUNOGLOBULIN LAMBDA-CHAINS; IMMUNOGLOBULIN LIGHT CHAINS; LIKELIHOOD FUNCTIONS; MULTIPLE MYELOMA; NEOPLASMS, PLASMA CELL; PREDICTIVE VALUE OF TESTS;

EID: 70350566145     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2009.09.021     Document Type: Article

References (15)

1. Pratt G. The evolving use of serum free light chain assays in haematology. Br J Haematol 141 (2008) 413-422
2. Vermeersch P., Van Hoovels L., Delforge M., Mariën G., and Bossuyt X. Diagnostic performance of serum free light chain measurement in patients suspected of a monoclonal B-cell disorder. Br J Haematol 143 (2008) 496-502
3. Katzmann J.A., Abraham R.S., Dispenzieri A., Lust J.A., and Kyle R.A. Diagnostic performance of quantitative kappa and lambda free light chain assays in clinical practice. Clin Chem 51 (2005) 878-881
4. Dispenzieri A., Kyle R., Merlini G., et al. International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders. Leukemia 23 (2009) 215-224
5. Palladini G., Russo P., Bosoni T., et al. Identification of amyloidogenic light chains requires the combination of serum-free light chain assay with immunofixation of serum and urine. Clin Chem 55 (2009) 499-504
6. Katzmann J.A., Clark R.J., Abraham R.S., et al. Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains. Clin Chem 48 (2002) 1437-1444
7. Hutchison C.A., Plant T., Drayson M., et al. Serum free light chain measurement aids the diagnosis of myeloma in patients with severe renal failure. BMC Nephrol 9 (2008) 11
8. Piehler A.P., Gulbrandsen N., Kierulf P., and Urdal P. Quantitation of serum free light chains in combination with protein electrophoresis and clinical information for diagnosing multiple myeloma in a general hospital population. Clin Chem 54 (2008) 1823-1830
9. Bradwell A.R., Carr-Smith H.D., Mead G.P., Harvey T.C., and Drayson M.T. Serum test for assessment of patients with Bence Jones myeloma. Lancet 361 (2003) 489-491
10. Drayson M., Tang L.X., Drew R., Mead G.P., Carr-Smith H., and Bradwell A.R. Serum free light-chain measurements for identifying and monitoring patients with nonsecretory multiple myeloma. Blood 97 (2001) 2900-2902
11. Vermeersch, P, Marien, G, Bossuyt X. More studies are needed to assess the performance of serum free light chain measurement for the diagnosis of B-cell disorders in routine clinical practice. Br J Haematol 2008;143:143-5.
12. Katzmann J.A., and Dispenzieri A. Screening algorithms for monoclonal gammopathies. Clin Chem 54 (2008) 1753-1755
13. Simel D.L., Samsa G.P., and Matchar D.B. Likelihood ratios with confidence: sample size estimation for diagnostic test studies. J Clin Epidemiol 44 (1991) 763-770
14. Dingli D., Kyle R.A., Rajkumar S.V., et al. Immunoglobulin free light chains and solitary plasmacytoma of bone. Blood 108 (2006) 1979-1983
15. Hill P.G., Forsyth J.M., Rai B., and Mayne S. Serum free light chains: an alternative to the urine Bence Jones proteins screening test for monoclonal gammopathies. Clin Chem 52 (2006) 1743-1748